Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.

Saved in:
Bibliographic Details
Title: Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
Authors: Hall, W A1, Petrova, A V1, Colbert, L E1, Hardy, C W1, Fisher, S B2, Saka, B3, Shelton, J W1, Warren, M D1, Pantazides, B G1, Gandhi, K4, Kowalski, J4, Kooby, D A5, El-Rayes, B F6, Staley, C A2, Volkan Adsay, N3, Curran, W J1, Landry, J C1, Maithel, S K2, Yu, D S1
Source: Oncogene. 11/20/2014, Vol. 33 Issue 47, p5450-5456. 7p.
Database: Academic Search Ultimate
Description
ISSN:09509232
DOI:10.1038/onc.2013.488